Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

VENDORS EVENT: HINJ and Somerset County Business Partnership to Host 2017 Life Sciences Vendors Procurement Conference on November 2

New Brunswick, NJ, October 18, 2017 — The HealthCare Institute of New Jersey’s (HINJ) annual Life Sciences Vendors Procurement Conference is scheduled for Thursday, November 2 from 8:00 to 11:30 a.m. at Raritan Valley Community College, Route 28 and Lamington Road, North Branch, NJ.

The event — entitled “How to Do Business with Pharma and Medical Technology Companies” — will be co-sponsored by the Somerset County Business Partnership (SCBP) with support from Eli Lilly and Company and Allergan.

Senator Kip Bateman (R-Somerset) will be the special guest speaker at the event that aims to educate businesses, large and small, on trends in procurement and issues of importance to the industry. Continue reading

Rowan, Rutgers, Camden County College Partner on Health Sciences; Joint Health Sciences Center Construction Begins

Camden, NJ, October 18, 2017 — With a ceremonial groundbreaking on October 19, local, state and federal officials are joining with the Rowan University/Rutgers-Camden Board of Governors (Joint Board of Governors) to celebrate the beginning construction of the Joint Health Sciences Center, an innovative facility that will provide unique education and training opportunities to a new generation of health care providers.

Set to open in the spring of 2019 at the intersection of Martin Luther King Blvd. and Broadway in downtown Camden, the Joint Health Sciences Center will be the first of its kind in New Jersey.

The construction of the 95,000 square-foot building will generate approximately $72 million in economic impact in the City of Camden alone.  Continue reading

Event: HINJ and Rutgers Biomedical Engineering Medical Device Development Center to Host Cybersecurity for Medical Devices’ on October 19; Second in Forum Series

New Brunswick, NJ, October 18, 2017 — Please join the Rutgers Biomedical Engineering Medical Device Development Center and the HealthCare Institute of New Jersey (HINJ) on Thursday, October 19 for “Cybersecurity for Medical Devices: Why and How,” which is the second in their Fall 2017 series of educational panels and seminars that focus on the medical device industry.

The forum will be held from 5:00 to 7:00 p.m. at Rutgers University Easton Auditorium (Busch Campus), 101 Bevier Road, Piscataway.  A networking reception will begin at 5:00 p.m.; the program will start at 5:30 p.m.

Medical device vulnerability to cybercrime is increasing, creating threats that can result in hospital data theft, patient identity theft and potential harmful impact to medical device safety and effectiveness.  Continue reading

Two New Jersey Residents Among 2017 MacArthur Foundation’s ‘Genius Grants’

Newark, NJ, October 18, 2017 — The MacArthur Foundation announced October 11 the 2017 recipients of its fellowship program, a prestigious award that promotes creativity and innovation with $625,000 awards.

Two of the 2017 class of MacArthur’s “genius grants” will go to two New Jersey residents, Jess Mazzola reported in The Star-Ledger/NJ.com.

The foundation describes the awards as “no-strings-attached” funding that goes to “extraordinarily talented and creative individuals as an investment in their potential.” Continue reading

NJ Innovation Institute and Rutgers Announce Plans to Form the New Jersey Continuous Manufacturing Institute to Advance Pharmaceutical Industry

Newark, NJ, October 17, 2017 — The New Jersey Innovation Institute (NJII), an NJIT Corporation, and Rutgers University announce plans to form the New Jersey Continuous Manufacturing Institute (NJCMI) to advance innovative manufacturing technologies in the pharmaceutical industry.

The NJCMI serves as a center of excellence combining state-of-the-art technologies, infrastructure, facilities and technical expertise to support the development and continuous manufacturing of products for the pharmaceutical industry.

In addition, it provides training, education and workforce development solutions for those who want to expand or gain additional training and expertise in pharmaceutical manufacturing. Continue reading

Stevens Institute of Technology Team Named Finalist in 2017 Collegiate Inventors Competition

Hoboken, NJ, October 17, 2017 — A Stevens Institute of Technology Senior Design team has been named one of only six undergraduate finalists for the 2017 Collegiate Inventors Competition, which honors the nation’s top collegiate inventors.

The students devised CerebroSense, a device that can monitor and measure exposed brain tissue from a distance, which reduces complications during and after open-brain surgery.

The Senior Design team, who have all graduated, includes David Ferrara, Andrew Falcone and Maria De Abreu Pineda. Continue reading

The College of New Jersey Cuts Ribbon on $76 Million, State-of-the-Art STEM Complex

Ewing, NJ, October 17, 2017 — New Jersey Governor Chris Christie, New Jersey Senate President Stephen M. Sweeney, Ewing Mayor Bert Steinmann, and The College of New Jersey President R. Barbara Gitenstein took part in a ribbon cutting ceremony on October 12 to officially open the college’s new, state-of-the-art STEM building, Chemistry addition, and Forum.

The cost of the project, which broke ground in July 2015, was $76,211,000, including $40 million provided through the Building Our Future Bond.

An additional $1.075 million in funding came from the New Jersey Higher Education Technology Infrastructure Fund. The college funded the balance through a variety of sources, including philanthropy. Continue reading

HINJ Hosts Life Sciences Celebration 2017; Honors Six for Meritorious Contributions

New Brunswick, NJ, October 13, 2017 ― Celebrating its 20th anniversary, the HealthCare Institute of New Jersey (HINJ) yesterday morning honored four individuals, a nonprofit patient advocacy organization and a public high school for their meritorious contributions in public service, medical innovation/human health, patient access/advocacy and STEM education.

The recipients of HINJ’s fifth annual honors — presented at the Historic Trenton Masonic Temple — were:

The Honorable Bob Franks Public Service Award

The Honorable Diane Allen
Member, New Jersey Senate (Burlington)

HINJ honored Senator Allen for her nearly 22 years of distinguished legislative service that has earned her a reputation as being one of the most effective patient advocates in the New Jersey Senate.  In the past year alone, Senator Allen, who will retire from the Senate in January, authored laws relating to elder abuse; domestic violence; improved support for veterans challenged with addiction and mental health issues; and the expansion of telemedicine, which is revolutionizing patient access to health care. Continue reading

PhRMA’s Chief Medical Officer on ‘The Next Five Years of PDUFA VI: Driving the Availability of Innovative Treatments for Patients’

Dr. Bill Chin

Washington, DC, October 13, 2017William “Bill” Chin, M.D., who serves as the chief medical officer of Pharmaceutical Research and Manufacturers of America (PhRMA) and leads the Scientific & Regulatory Advocacy department as executive vice president, wrote the following on PhRMA’s blog, The Catalyst, on October 2:

Yesterday, October 1, marked the first day of implementation for PDUFA VI, the next iteration of the Prescription Drug User Fee Act (PDUFA) and one of the best tools that the U.S. Food and Drug Administration (FDA) has for enhancing regulatory efficiency and encouraging innovative development of safe and effective new medicines for patients.

First enacted in 1992, PDUFA allows the FDA to collect user fees from biopharmaceutical companies to help support the agency’s process for review of new drugs and biologics. Continue reading

WSJ Analysis Finds Nine of 10 Largest College STEM Programs Increased Share of Women Graduates

New York, NY, October 13, 2017 — Melissa Korn reports in The Wall Street Journal that as more high-paying jobs require a degree and expertise in things like computer coding or mechanical engineering, colleges and universities are racing to fill a pronounced void in qualified candidates.

One place they are making extra effort is among women.

The U.S. Labor Department estimates there will be 510,900 engineering job openings in the U.S. by 2024, and another 426,900 software development and programming jobs will be available, all requiring at least a bachelor’s degree. Continue reading